Here are some of the problems and use cases $BIO token will have.
1. High cost for making new drugs.
2. High failure rates (90%+)
3. Concentration of funding in a few geographic hubs
4. Limited access to early-stage biotech investments for most people
5. Misaligned incentives between scientists, patients and pharma industry
Solutions? Here they are :
1. BIO transforms the way early-stage scientific research is financed and commercialized using blockchain technology.
2. Rather than the top-down structure of Academia and Big Pharma, BIO accelerates science from the ground-up through community consensus, scientific rigor and adaptive onchain tooling.
3. The protocol incubates and accelerates BioDAOs — from creation to funding, incentives, liquidity and beyond, taking a percentage stake in each incubated BioDAO.
4. The protocol incubates and accelerates BioDAOs — from creation to funding, incentives, liquidity and beyond, taking a percentage stake in each incubated BioDAO.
5. BIO token is your key to the DeSci economy, giving holders whitelisted access to initial BioDAO offerings and the ability to direct funding across the DeSci economy.
6. BIO protocol is founded by key members of VitaDAO—the BioDAO backed by Pfizer Ventures and Balaji Srinivasan.
AND MORE.
An outstanding token, BIO Protocol launches 3rd January 2025.